{"created":"2023-05-15T14:45:35.831942+00:00","id":62302,"links":{},"metadata":{"_buckets":{"deposit":"26fede7d-4ac7-4813-aa01-478461b23110"},"_deposit":{"created_by":1,"id":"62302","owners":[1],"pid":{"revision_id":0,"type":"depid","value":"62302"},"status":"published"},"_oai":{"id":"oai:repo.qst.go.jp:00062302","sets":["10:29"]},"author_link":["615826","615825","615828","615827"],"item_10005_date_7":{"attribute_name":"発表年月日","attribute_value_mlt":[{"subitem_date_issued_datetime":"2007-11-06","subitem_date_issued_type":"Issued"}]},"item_10005_description_5":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"【目的】gliomaなど頭蓋内原発腫瘍術前に11C- methionine PET（MET-PET）を施行し、画像所見と病理組織の悪性度とを比較検討した。【方法】対象症例は男性22名、女性9名。年齢14〜75歳（平均46.9歳）。glioma30例、malignant lymphoma1例。MET集積の程度は半定量的指標（TNR：腫瘍正常脳比）によって求めた。【結果】astroctytoma系のgliomaでは組織悪性度が高いほどTNR高値の傾向を示した。glioblastomaは全例でTNR2以上の高値であった。oligodendroglioma系ではgradeが低いものでもTNRは高値であった。しかし病理上悪性度が高いanaplastic oligoastroctyomaの1例でTNR低値（0.4）を示し、malignant lymphoma1例で病理所見で腫瘍内梗塞を認めTNR低値（0.5）であった。【結論】悪性度の高いgliomaやmalignant lymphomaでは、組織所見が悪性であってもMET低集積の例がある。限界を理解した上でMET-PETを活用することが重要である。","subitem_description_type":"Abstract"}]},"item_10005_description_6":{"attribute_name":"会議概要（会議名, 開催地, 会期, 主催者等）","attribute_value_mlt":[{"subitem_description":"第47回日本核医学会学術総会","subitem_description_type":"Other"}]},"item_access_right":{"attribute_name":"アクセス権","attribute_value_mlt":[{"subitem_access_right":"metadata only access","subitem_access_right_uri":"http://purl.org/coar/access_right/c_14cb"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"内野, 福生"}],"nameIdentifiers":[{"nameIdentifier":"615825","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"吉川, 京燦"}],"nameIdentifiers":[{"nameIdentifier":"615826","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"内野 福生","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"615827","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"吉川 京燦","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"615828","nameIdentifierScheme":"WEKO"}]}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"conference object","resourceuri":"http://purl.org/coar/resource_type/c_c94f"}]},"item_title":"脳腫瘍における11C-Methionine PETの有用性と限界","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"脳腫瘍における11C-Methionine PETの有用性と限界"}]},"item_type_id":"10005","owner":"1","path":["29"],"pubdate":{"attribute_name":"公開日","attribute_value":"2007-11-09"},"publish_date":"2007-11-09","publish_status":"0","recid":"62302","relation_version_is_last":true,"title":["脳腫瘍における11C-Methionine PETの有用性と限界"],"weko_creator_id":"1","weko_shared_id":-1},"updated":"2023-05-15T21:32:19.416981+00:00"}